Wall Street is trying to figure out whether the U.S. insurance industry will bear any costs from a record $4.69 billion judgment against Johnson & Johnson awarded to customers and their families who claimed that asbestos-contaminated talc caused ovarian cancer. …
from News – Insurance Journal https://ift.tt/2O2aDQt
via
IFTTT
No comments:
Post a Comment